Theodore James Jr. Washburn - Feb 1, 2023 Form 4 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)

Role
Principal Accounting Officer
Signature
/s/ William Cook, as attorney-in-fact for Theodore James Jr. Washburn
Stock symbol
AGIO
Transactions as of
Feb 1, 2023
Transactions value $
-$7,764
Form type
4
Date filed
2/14/2023, 03:06 PM
Previous filing
Mar 3, 2022
Next filing
Feb 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGIO Common stock Options Exercise $0 +777 +29.12% $0.00 3.45K Feb 10, 2023 Direct F1
transaction AGIO Common stock Tax liability -$7.76K -273 -7.92% $28.44 3.17K Feb 14, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGIO Restricted stock units Award $0 +6.9K $0.00 6.9K Feb 1, 2023 Common stock 6.9K Direct F2, F3
transaction AGIO Restricted stock units Options Exercise $0 -777 -50% $0.00 777 Feb 10, 2023 Common stock 777 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 119 shares purchased through the Company's employee stock purchase plan.
F2 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F3 The restricted stock units were granted on February 1, 2023. The shares underlying the restricted stock units will vest in full on February 1, 2025.
F4 The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments.